Search research articles
Contact Us
Filters
Showing results (61-70 of 452) with videos related to
Page
of 46
Sort By:
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia
|
March 17, 2009
Understanding the dopaminergic deficits in Parkinson's disease: insights into disease heterogeneity
Simon J G Lewis, Roger A Barker
The Journal of Clinical Investigation
|
June 4, 2013
A new approach to disease-modifying drug trials in Parkinson's disease
Roger A Barker, Mark Stacy, Patrik Brundin
Journal of Neurology
|
March 25, 2010
How vital is sleep in Huntington's disease?
Anna O G Goodman, Roger A Barker
Parkinsonism & Related Disorders
|
October 22, 2008
A pathophysiological model of freezing of gait in Parkinson's disease
Simon J G Lewis, Roger A Barker
Neurosurgical Focus
|
March 18, 2008
Cell therapy in Huntington disease
Claire D Clelland, Roger A Barker, Colin Watts
Journal of Neurology
|
December 12, 2024
An update on immune-based alpha-synuclein trials in Parkinson's disease
Maha Alfaidi, Roger A Barker, Wei-Li Kuan
Stem Cells and Development
|
July 19, 2006
Neurogenesis in diseases of the central nervous system
Wendy Phillips, Andrew W Michell, Roger A Barker
Movement Disorders : Official Journal of the Movement Disorder Society
|
May 11, 2004
SCA2 presenting as levodopa-responsive parkinsonism in a young patient from the United Kingdom: a case report
Alastair Wilkins, Jerry M Brown, Roger A Barker
Movement Disorders : Official Journal of the Movement Disorder Society
|
June 27, 2008
The current clinical management of Huntington's disease
Wendy Phillips, Kathleen M Shannon, Roger A Barker
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia
|
April 27, 2013
L-dopa responsive parkinsonism secondary to a subdural haematoma
Mark A Ellul, Justin Cross, Roger A Barker
Page
of 46
Search research articles
Search
Showing results (61-70 of 452) with videos related to
Sort By:
Page
of 46
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia
|
March 17, 2009
Understanding the dopaminergic deficits in Parkinson's disease: insights into disease heterogeneity
Simon J G Lewis, Roger A Barker
The Journal of Clinical Investigation
|
June 4, 2013
A new approach to disease-modifying drug trials in Parkinson's disease
Roger A Barker, Mark Stacy, Patrik Brundin
Journal of Neurology
|
March 25, 2010
How vital is sleep in Huntington's disease?
Anna O G Goodman, Roger A Barker
Parkinsonism & Related Disorders
|
October 22, 2008
A pathophysiological model of freezing of gait in Parkinson's disease
Simon J G Lewis, Roger A Barker
Neurosurgical Focus
|
March 18, 2008
Cell therapy in Huntington disease
Claire D Clelland, Roger A Barker, Colin Watts
Journal of Neurology
|
December 12, 2024
An update on immune-based alpha-synuclein trials in Parkinson's disease
Maha Alfaidi, Roger A Barker, Wei-Li Kuan
Stem Cells and Development
|
July 19, 2006
Neurogenesis in diseases of the central nervous system
Wendy Phillips, Andrew W Michell, Roger A Barker
Movement Disorders : Official Journal of the Movement Disorder Society
|
May 11, 2004
SCA2 presenting as levodopa-responsive parkinsonism in a young patient from the United Kingdom: a case report
Alastair Wilkins, Jerry M Brown, Roger A Barker
Movement Disorders : Official Journal of the Movement Disorder Society
|
June 27, 2008
The current clinical management of Huntington's disease
Wendy Phillips, Kathleen M Shannon, Roger A Barker
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia
|
April 27, 2013
L-dopa responsive parkinsonism secondary to a subdural haematoma
Mark A Ellul, Justin Cross, Roger A Barker
Page
of 46